Introduction
Monascus species are used to produce Monascusfermented rice (MFR) (also called red mold rice, red yeast rice, and red-koji). MFR has been used for thousands of years in East Asian countries to produce fermented foods such as red-rice wine and fermented soybean curd [12] . MFR has also been used as a folk medicine to improve blood circulation, and spleen and stomach health, and its pharmaceutical properties have been described in the ancient Chinese pharmacopeia, Ben Cao Gang Mu by ShiZhen Li (1518 -1593 . Such health-promoting effects of MFR have been supported by findings of various bioactive compounds such as angiotensin-converting enzyme (ACE)-inhibitory peptides, γ-aminobutyric acid (GABA), monacolins, pigments, and dimerumic acid (reviewed in [12, 17] ). In addition to its traditional use, MFR is being developed as a functional food or food supplement with hypolipidemic effects, because it contains monacolin K (also known as mevinolin or lovastatin), which is known to reduce blood cholesterol levels [7] .
Recently, substrates besides rice, including garlic, dioscorea, red ginseng, and soybean, have been used to prepare Monascus-fermented products (reviewed in [13] ). For example, monacolin K-enriched mugwort is developed by fermentation with Monascus pilosus [15] . Because Monascus species produce a wide range of bioactive compounds, Monascus-fermented products may contain other bioactive compounds in addition to the intrinsic ones. During the fermentation of some substances, Monascus species provide an additional advantage of transforming intrinsic bioactive substances to ones with improved functionality. Monascusfermented red ginseng contains high levels of monacolin K and deglycosylated ginsenosides, and it could offer improved health benefits owing to the additional bioactive compounds and readily absorbable deglycosylated ginsenosides produced by fermentation with M. pilosus [9] .
Most of the health-promoting compounds in Monascusfermented products are fungal secondary metabolites (SMs). Recent genomic studies in several fungi have revealed the presence of additional SM gene clusters than expected in a given fungus, suggesting that many SM gene clusters are not fully expressed under standard laboratory or industrial culture conditions [5, 6, 29] . Therefore, it would be possible to improve the fungal production of bioactive compounds by activating SM gene clusters. LaeA would be a good target for improving SM production, because it controls SM production in several filamentous fungi [3] . In Aspergillus nidulans, overexpression of the laeA gene activated the terrequinone A biosynthetic gene cluster, leading to the discovery of terrequinone A, which had previously not been identified in this fungus [2] . Perrin et al. [20] reported that LaeA positively regulates 20-40% of SM gene clusters in Aspergillus fumigatus. Overexpression of laeA also increased penicillin production by 25% in Penicillium chrysogenum [11] . Therefore, we hypothesized that the overexpression of a laeA ortholog in Monascus species would lead to the activation and/or elevation of SM production, thereby making Monascus strains more valuable in functional foodprocessing applications. In this study, we constructed a laeA-overexpressing M. pilosus strain and evaluated its applicability in MFR production.
Materials and Methods

Chemicals and Media
Monacolin K and cyclopentanone were purchased from Sigma Aldrich Chemical Co. (USA) and Merck Schuchardt OHG (Germany), respectively. All HPLC-grade solvents were from Mallinckrodt Baker (USA). Rice was purchased from a local market in Seoul City (Korea). Potato dextrose agar (PDA) and potato dextrose broth (PDB) were from Acumedia (USA). A lactose minimal medium (LMM) was used for both uninduced and induced cultures, and cyclopentanone was added to a final concentration of 10 mM in induced cultures only. LMM has the same composition as GMM [23] , except that glucose is replaced with 2% lactose in LMM. GMM containing cyclopentanone was used for repressed cultures.
Fungal Strains and Culture Conditions
Monascus pilosus IFO4480 was purchased from the Korean Culture Center for Microorganisms (KCCM, Seoul, Korea). It was routinely grown on PDA at 30 o C. Aspergillus nidulans H109 was obtained from Prof. Nancy P. Keller (University of WisconsinMadison, WI, USA).
Spores of M. pilosus were harvested using a 0.8% saline buffer after culturing the strains on PDA plates for 5 days at 30 o C. Spores were inoculated into liquid medium at 1.0 × 10 7 spores/ml. All broth cultures were incubated at 30 o C with shaking (150 rpm).
Molecular Genetic Manipulation and Southern Analysis
DNA manipulations and Southern analysis were performed according to standard procedures [22] . Fungal DNA was isolated as described previously [23] . The PCR primers used are listed in Table 1 . For probe labeling and detection in Southern analysis, a digoxigenin (DIG)-DNA labeling and detection kit was used according to the manufacturer's instructions (Roche, Basel, Switzerland).
Cloning and Overexpression of the M. pilosus laeA Gene
When this study was initiated, no laeA gene sequence was available for Monascus spp. We had previously cloned and sequenced the Monascus ruber laeA gene (Kim and Lee, unpublished data). Based on the M. ruber laeA gene sequence, we designed PCR primers (laeAF and laeAR) to amplify 3.8 kb fragments including the laeA open reading frame (ORF) and 5'-and 3'-flanking sequences (1.2 and 1.4 kb, respectively), The PCR fragments were sequenced by Macrogen (Korea). The alcA promoter was amplified from genomic DNA of A. nidulans H109 by using the primers OEF and OER. The laeA promoter was replaced by the alcA promoter by single-joint Table 1 . Primers used in this study. 
